![](https://monteverdelaw.com/wp-content/uploads/case-logo/myos-rens-technology-inc.jpg)
MYOS RENS Technology, Inc. (MYOS) relating to its merger with MedAvail, Inc. Under the terms of the agreement, MYOS shareholders receive a dividend of a MYOS subsidiary, and MYOS shareholders will own only 3.5% of the new combined company. The remaining 96.5% of the new entity will be owned by MedAvail’s security holders and new investors.